WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma

• Mark Richter,

  Affiliation Oncology R&D, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, United States of America

  ⨯
• Tajhal Dayaram,

  Affiliation Department of Molecular Virology and Microbiology and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Aidan G. Gilmartin,

  Affiliation Oncology R&D, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, United States of America

  ⨯
• Gopinath Ganji,

  Affiliation Oncology R&D, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, United States of America

  ⨯
• Sandhya Kiran Pemmasani,

  Affiliation Ocimum Biosolutions Ltd., HUDA Techno Enclave, Hyderabad, AP, India

  ⨯
• Harjeet Van Der Key,

  Affiliation Platform Technology & Science, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, United States of America

  ⨯
• Jason M. Shohet,

  Affiliation Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Lawrence A. Donehower ,

  * E-mail: larryd@bcm.edu (LAD); rakesh.2.kumar@gsk.com (RK)

  Affiliation Department of Molecular Virology and Microbiology and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Rakesh Kumar

  * E-mail: larryd@bcm.edu (LAD); rakesh.2.kumar@gsk.com (RK)

  Affiliation Oncology R&D, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania, United States of America

  ⨯